Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
SEC filings, financial facts, source resources, and Goglides workspace context for Gilead Sciences, Inc..
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
A filing-led Datavault AI deep dive covering Q1 2026 results, product architecture, RWA tokenization, SanQtum GPU infrastructure, NYIAX/CyberCatch/DelivMeds optionality, HELMEX structured financing, dilution, and the proof gates that matter next.
OpenGilead reported 2025 revenue of $29.44 billion and Q1 2026 revenue of $6.96 billion. The thesis turns on whether HIV durability and cash generation can keep funding oncology, inflammation and pipeline expansion while patent, clinical and debt risks stay contro
OpenA filing-led Datavault AI Q1 2026 earnings thesis focused on recognized revenue, tokenization contracts, cash conversion, losses, liquidity, and dilution risk.
OpenAmbitions is a profitable Dubai MICE and tourism services operator with $20.2 million of fiscal 2025 revenue, but the public-equity case carries newly public issuer, founder-control, internal-control, cash-conversion and listing-risk watch items.
OpenTag facets appear after tag usage counts are rebuilt.